The Weekly Roundup: September 11-15

POLL: Which Aspect of Alopecia Awareness Do You Feel Needs The Most Improvement?

This Alopecia Awareness Month, we want to know your thoughts on necessary action points to improve alopecia awareness. Click here to answer this week's poll.

Deucravacitinib: A Year in Review

As deucravacitinib surpasses its 1-year milestone since approval, clinicians continue to monitor its real-world performance among patients.

World Trade Center 9/11 Rescue Workers Show Higher Risk of Melanoma

Rescue workers had a higher rate of malignant melanoma between 2005 and 2015 compared the general population of New York State.

Steven Dayan, MD, FACS: Prioritizing Patient Satisfaction in Cosmetic Dermatology

Steven Dayan, MD, FACS, first author behind a recent study involving high rates of patient satisfaction following treatment with botulinum toxin, discusses the importance of placing patient satisfaction at the forefront of cosmetic dermatology.

Mallinckrodt Receives FDA Label Update for StrataGraft Xenotransplantation Requirements

The FDA no longer restricts the donation of human cells, tissues, cellular or tissue-based products, human milk, ova, sperm, or organs for transplantation for patients who receive StrataGraft.

CALL FOR RESEARCH AND INSIGHTS: Share Your Atopic Dermatitis, Eczema Insights With Us

Share your insights ahead of October's National Eczema Awareness Month by emailing our team at DTEditor@mmhgroup.com.

A Spotlight on Innovations and Considerations

A panel of leading dermatologists discuss the efficacy and considerations of treating plaque psoriasis with deucravacitinib as September marks the 1-year anniversary of the approval of the drug.

Arcutis Submits sNDA for Roflumilast Cream in the Treatment of Atopic Dermatitis in Patients 6 and Older

The submission follows the announcement of recent long-term data of the drug in patients ages 6 years and older.

Izokibep Fails in Phase 2b/3 Hidradenitis Suppurativa Trial

The IL-17A inhibitor did not meet its phase 2b/3 clinical trial primary end point.

Pointers With Portela: Moisturizers for All Skin Types

In this week’s Pointers With Portela, the 208SkinDoc recommends products for dry, oily, sensitive, and acne-prone skin types.

Donepezil Patch Shows Favorable Results on Skin Irritation Trial

The donepezil transdermal system to treat dementia showed no to minimal skin irritation in the study.

Finasteride and Hydroxychloroquine Deemed Equally Effective in Treatment of Frontal Fibrosing Alopecia

Researchers compared the efficacy of the 2 modalities and found that they were equal in safety, efficacy, and tolerability.

Surgical Excision Successful in Treating Folliculitis Decalvans

After 17 months, patients showed no signs of remission.

Taking a Proactive Approach to Aging

In this month's letter from the Editor in Chief, Zoe Diana Draelos, MD, explains why aging is a culmination of disease processes and that more steps should be taken to address aging.

Confronting Racial Disparities in Dermatologic Education

To further discuss the changing landscape of skin of color representation in dermatology, Christopher Bunick, MD, PhD, and Shawn Kwatra, MD, review how they have seen representation change in their own experiences.

Phase 1b Study of Rezpegaldesleukin in Moderate-to-Severe AD Met Clinical Efficacy Endpoints

Nektar Therapeutics announced the promising and statistically significant results, which included meeting endpoints of BSA, DLQI and POEM in patients with atopic dermatitis.

Frontline Forum Part 1: Improving Basal Cell Carcinoma Management

In part 1 of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, discuss non-surgical treatment options for the management of BCC, dose adjustments for systemic treatments, combining hedgehog pathway inhibitors with immunotherapy, and more.

Use of High-Frequency Ultrasound Can Improve Diagnostic Accuracy and Determinacy of Subcutaneous Lesions

Indeterminacy of invisible subcutaneous lesions such as epidermoid cysts, lipomas, pilomatrixomas, hemangiomas, and DFSPs, can be decreased with HFUS use, according to investigators.

Journal Digest: September 13

This week’s collection of the latest dermatologic studies covers aseptic facial granulomas, chronic spontaneous urticaria and IgE, a case review of crusted scabies, and the safety and tolerability of onabotulinumtoxinA.

Rosehip Oil Showed Significant Improvement in Scar Healing

Treatment groups showed faster healing and lower rates of erythema than control groups.

“Moving Ahead” Campaign Will Raise Awareness About Atopic Dermatitis

World Atopic Eczema Day initiative from Almirall highlights experiences and facts about atopic dermatitis.

Maximize Device Options for Acne and Acne Scarring

Treatments using lasers and microneedling for acne and acne scarring have grown in recent years, offering patients more options.

Atopic Dermatitis, Systemic Inflammation Not Linked to Dementia Risk

According to researchers, only 3 studies have previously explored a potential link between AD and dementia with inconsistent findings.

First Patient Dosed in Phase 2 Trial of Bempikibart for Alopecia Areata

Bempikibart offers a new approach to treating the disease by blocking signaling pathways.

Understanding the Role of Amino Acids and Proteins in Skin Care

In this month's Cosmetic Conundrums column, Zoe Diana Draelos, MD, describes peptides and their use in skin care.

Long Pulsed ND:YAG Laser Efficacious in Treatment of Plane Warts

In a study of 19 patients, the laser treatment led to excellent responses in 86.36% of participants, with 78.94% achieving complete response.

Insights Into Aesthetic Next With Katie Martin, PA-C

Martin presented clinical pearls regarding business management and facial balancing in Dallas, Texas.

Dermatologic Concerns and Disparities Among Members of the Hispanic Community

This Hispanic Heritage Month, Dermatology Times is reviewing the unique dermatologic concerns and disparities faced by members of the Hispanic community.

Frontline Forum Part 2: Improving Basal Cell Carcinoma Management

In part 2 of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, discuss non-surgical treatment options for the management of BCC, dose adjustments for systemic treatments, combining hedgehog pathway inhibitors with immunotherapy, and more.

Lebrikizumab Receives Positive Opinion for Atopic Dermatitis Treatment in Europe

Skin clearance and itch relief were maintained through 1 year of treatment with monthly maintenance.

Skin of Color Resources for Clinicians

Websites and educational materials are available to support clinicians in treating their patients with skin of color.

GRAPPA Continues Efforts to Advance Care for Patients With Plaque Psoriasis

The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis provides an opportunity for clinicians to share knowledge and research.